Detalhe da pesquisa
1.
First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial.
Lancet
; 397(10272): 375-386, 2021 01 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33485464
2.
Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer.
N Engl J Med
; 379(21): 2040-2051, 2018 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30280635
3.
Brigatinib in ALK-positive non-small cell lung cancer: real-world data in the Latin American population (Bri-world extend CLICaP).
Future Oncol
; 17(2): 169-181, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32986959
4.
National Clinical Practice Guidelines for the management of non-small cell lung cancer in early, locally advanced and metastatic stages. Extended version. / Guía de Práctica Clínica Nacional para el manejo del cáncer de pulmón de células no pequeñas en estadios tempranos, localmente avanzados y metastásicos.
Salud Publica Mex
; 61(3): 359-414, 2019.
Artigo
em Espanhol
| MEDLINE | ID: mdl-31276353
5.
Mutation profile in liquid biopsy tested by next generation sequencing in Mexican patients with non-small cell lung carcinoma and its impact on survival.
J Thorac Dis
; 16(1): 161-174, 2024 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38410597
6.
Role of sex and sex hormones in PD-L1 expression in NSCLC: clinical and therapeutic implications.
Front Oncol
; 13: 1210297, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37941543
7.
Pembrolizumab Plus Chemotherapy in Squamous Non-Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study.
J Clin Oncol
; 41(11): 1999-2006, 2023 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36735893
8.
Epirubicin, cisplatin plus ifosfamide versus standard chemotherapeutic regimens for advanced/unresectable primary thoracic sarcomas.
J Cancer Res Clin Oncol
; 149(9): 5479-5491, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36463530
9.
Survival prognostic factors in unresectable/advanced primary thoracic sarcomas.
J Thorac Dis
; 14(9): 3376-3385, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36245612
10.
Paraneoplastic Cerebellar Degeneration with Anti-CV2/CRMP5 Antibodies in Ovarian Cancer: Case Report and Review of the Literature.
Case Rep Oncol
; 14(3): 1799-1805, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35111012
11.
Myoepithelial Carcinoma Arising in a Plasmacytoid Myoepithelioma of the Parotid Gland Synchronized with Melanoma: A Case Report and Review of the Literature.
Case Rep Oncol
; 14(1): 173-183, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33776700
12.
Outcomes With Pembrolizumab Plus Platinum-Based Chemotherapy for Patients With NSCLC and Stable Brain Metastases: Pooled Analysis of KEYNOTE-021, -189, and -407.
J Thorac Oncol
; 16(11): 1883-1892, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34265431
13.
Prognostic factors for progression-free and overall survival in malignant pleural mesothelioma.
Thorac Cancer
; 12(7): 1014-1022, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33660947
14.
Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451.
J Clin Oncol
; 39(12): 1349-1359, 2021 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33683919
15.
A comparative study of immunotherapy as second-line treatment and beyond in patients with advanced non-small-cell lung carcinoma.
Lung Cancer Manag
; 10(3): LMT47, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34408789
16.
Efficacy and Safety of Nivolumab Plus Ipilimumab versus Sunitinib in First-line Treatment of Patients with Advanced Sarcomatoid Renal Cell Carcinoma.
Clin Cancer Res
; 27(1): 78-86, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32873572
17.
Surgical care of thoracic malignancies during the COVID-19 pandemic in México: An expert consensus guideline from the Sociedad Mexicana de Oncología (SMeO) and the Sociedad Mexicana de Cirujanos Torácicos Generales (SMCTG).
Thorac Cancer
; 11(8): 2370-2375, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32627963
18.
Human skin biomarkers relationship to response to treatment with tyrosine kinase inhibitors in advanced EGFR-mutated lung adenocarcinoma.
Thorac Cancer
; 11(11): 3243-3251, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33015988
19.
A Randomized, Placebo-Controlled Trial of Pembrolizumab Plus Chemotherapy in Patients With Metastatic Squamous NSCLC: Protocol-Specified Final Analysis of KEYNOTE-407.
J Thorac Oncol
; 15(10): 1657-1669, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32599071
20.
Health-Related Quality of Life With Carboplatin-Paclitaxel or nab-Paclitaxel With or Without Pembrolizumab in Patients With Metastatic Squamous Non-Small-Cell Lung Cancer.
J Clin Oncol
; 38(3): 271-280, 2020 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31751163